Publication
Patient-derived organoids as predictor of clinical response in ovarian cancer: a systematic review.
Merel Vegter, Prakriti Garkhail, Gatske M Nieuwenhuyzen-de Boer, Ingrid A Boere, Heleen J van Beekhuizen
Translational oncologySep 6, 2026PMID 42702147doi:10.1016/j.tranon.2026.103017 Journal ArticleReviewpubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 13, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260913-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Patient-derived organoids (PDOs) have emerged as promising preclinical models for functional drug testing in ovarian cancer, with potential to support personalized treatment selection. However, their predictive value for clinical treatment response remains unclear. This systematic review evaluated…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Ovarian Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.